학술논문
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
Document Type
Article
Author
Leal, Lorna; Pich, Judit; Ferrer, Laura; Nava, Jocelyn; Martí-Lluch, Ruth; Esteban, Ignasi; Pradenas, Edwards; Raïch-Regué, Dàlia; Prenafeta, Antoni; Escobar, Karla; Pastor, Carmen; Ribas-Aulinas, Marc; Trinitè, Benjamin; Muñoz-Basagoiti, Jordana; Domenech, Gemma; Clotet, Bonaventura; Corominas, Júlia; Corpes-Comes, Aida; Garriga, Carme; Barreiro, Antonio
Source
NPJ Vaccines; 9/29/2023, Vol. 8 Issue 1, p1-12, 12p
Subject
Language
ISSN
20590105
Abstract
Copyright of NPJ Vaccines is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)